Insights On Outsourced Drug Development

1. Bioanalytical Quantification Of A Biotherapeutic Peptide 7/17/2025

   Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.

2. Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency 9/25/2025

   Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.

3. LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting 7/29/2025

   Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.

4. Enhancing Throughput And Reproducibility In Proteomic Analysis 8/27/2025

   Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.

5. EMA Support For Rare Disease Therapies 6/10/2025

   Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.

6. Accelerating The Study Of Viral Infection And Therapeutics 8/7/2024

   Explore the utilization of the Organ-Chips for investigating viral infections and expediting the development of new therapeutics.

7. Formulation Strategies For Enabling "Undevelopable" Compounds 4/29/2025

   KinetiSol enhances bioavailability of poorly soluble drugs like Vemurafenib by producing dense amorphous dispersions, outperforming traditional MBP methods in pharmacokinetics and dissolution.

8. Utilizing The Colon Intestine-Chip To Investigate Mechanisms Of Gastrointestinal Disease 8/2/2024

   What are the application and benefits of Organ-Chips and what makes them superior to organoids in the study of GI-related diseases?

9. A Novel Patient-Derived Colorectal Cancer Organoid Platform 4/22/2025

   Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.

10. High Potency APIs And The Evolving Demands Of Drug Development 4/13/2026

    See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.